PPD (PPD) Akcija Цена

PPD Цена

NASDAQ·ZATVORENO
47,28
​
Tržište je zatvoreno

Prihod je rastao 15,0 % godišnje u poslednjih 4 godina na 4,68 Млрд USD. Zarada po akciji padala je 5,9 % godišnje u poslednjih 4 godina. neto marža kompanije PPD sada iznosi 3,3 %, pala sa 6,8 % pre nekoliko godina.

Cena akcije PPD

Pristupite ovim podacima preko Eulerpool API-ja

100.000 zahteva/mes. besplatno · bez kartice

PPD poslovni model i analiza akcije

PPD Inc je globalna kompanija za medicinska istraživanja i usluge, osnovana 1985. godine sa sedištem u Vilmingtonu, Severna Karolina, SAD. Kompanija je poznata po svojoj sposobnosti da sprovodi klinička ispitivanja i razvija istraživačke programe za biofarmaceutsku i medicinsku industriju. PPD je vodeći pružalac sveobuhvatnih, integrisanih usluga za faze I-IV kliničkih istraživanja, od neinterventivnih studija do ugovornih istraživanja za farmaceutske i biotehnološke klijente. Poslovni model PPD-a zasnovan je na tri ključna stuba kako bi kupcima ponudio širok portfolijo usluga: prvi stub obuhvata sveobuhvatna klinička istraživanja potrebna za registraciju lekova kod regulatornih tela; drugi stub se fokusira na pružanje podataka zasnovanih na istraživanjima i analitičkih metoda koje olakšavaju donošenje odluka i procenu rizika u sektoru zdravstva; a treći stub obuhvata opsežne laboratorijske analize i dijagnostičke testove radi poboljšanja zdravlja pacijenata i podrške naporima u istraživanju. PPD ima više odeljenja usmerenih na specifična tržišta i kupce. Odeljenje za klinička ispitivanja nudi usluge za razvoj lekova do odobrenja regulatornih tela, uključujući uspostavljanje i nadzor kliničkih ispitivanja kao i statističku analizu rezultata testova. Odeljenje za upravljanje podacima pruža rešenja za prikupljanje i upravljanje podacima u kliničkim ispitivanjima kako bi se osigurala visoka kvalitetnost podataka i usklađenost sa propisima. Odeljenje za medicinski nadzor nudi medicinske konsultacije i nadzor tokom kliničkih ispitivanja. PPD takođe ima odeljenje za studije stvarnog sveta (Real World Evidence), koje prikuplja podatke iz rutinske kliničke prakse radi procene bezbednosti i efikasnosti lekova. PPD je u prošlosti izvršila nekoliko važnih akvizicija kako bi ojačala svoju prisutnost u industriji. Godine 2011. PPD su preuzele privatne ekuitetne firme Carlyle Group i Hellman & Friedman, čime je postala privatna kompanija. Godine 2020. PPD je izašla na berzu. Godine 2018. PPD je akvizirala Evidera, kompaniju specijalizovanu za kliničku epidemiologiju i istraživanje ishoda. Godine 2019. PPD je akvizirala Q-Squared Solutions, proširivši svoje kapacitete za opsežne laboratorijske analize i dijagnostičko testiranje. Ponuda PPD-a uključuje širok spektar proizvoda i usluga, uključujući jedinstvena rešenja za planiranje i implementaciju koja omogućavaju efikasno sprovođenje kliničkih ispitivanja. Ova rešenja takođe uključuju sisteme za elektronsko prikupljanje i upravljanje podacima, kao i alate za statističku analizu. PPD takođe nudi specijalizovane usluge, kao što su programi obuke za kliničke istraživače i osoblje. PPD teži da omogući bezbedan, brži i ekonomičniji razvoj lekova kroz klinička istraživanja. U budućnosti, PPD će nastaviti da širi svoj poslovni model i usluge kako bi zadovoljila potrebe svojih kupaca u promenljivoj industriji i podržala inovativne istraživačke programe.

Često postavljana pitanja o akciji PPD

PPD Inc is a leading global contract research organization (CRO) providing comprehensive, integrated drug development and laboratory services. Their business model revolves around offering end-to-end solutions to pharmaceutical and biotech companies, guiding them through the entire drug development process. PPD Inc offers a wide range of services including clinical research, data management, biostatistics, and regulatory affairs. With a focus on quality, efficiency, and innovation, PPD Inc helps clients accelerate the development of life-changing therapies. Through their extensive expertise, efficient processes, and strategic partnerships, PPD Inc plays a crucial role in advancing healthcare outcomes and bringing new treatments to patients worldwide.

PPD Inc is primarily active in the pharmaceutical and biotechnology industries.

The main competitors of PPD Inc in the market include QuintilesIMS, LabCorp, Icon, and Covance.

PPD Inc is a leading global contract research organization (CRO) specializing in drug development, laboratory services, and clinical trial management. Founded in 1985, PPD has a rich history and a strong background in providing innovative solutions to the pharmaceutical, biotechnology, and medical device industries. The company offers a comprehensive range of services, including early development, clinical research, laboratory services, and post-approval studies. PPD Inc has established itself as a trusted partner for the life sciences industry, delivering high-quality results, efficiency, and expertise in advancing healthcare solutions. With a global presence and a team of experienced professionals, PPD continues to be at the forefront of advancing clinical research and improving patient outcomes.

PPD Inc has achieved significant milestones throughout its history. Some noteworthy achievements include successfully conducting over 230,000 clinical trials, establishing a global presence in more than 46 countries, and consistently delivering innovative solutions to the life sciences industry. The company has also been recognized for its exceptional expertise in clinical research, data management, and regulatory affairs. PPD Inc's commitment to quality and customer satisfaction has enabled it to be a reliable partner for pharmaceutical, biotechnology, and medical device companies worldwide. With its strong track record and industry leadership, PPD Inc continues to make significant strides in advancing healthcare and improving patient outcomes.

PPD Inc primarily operates in over 50 countries and regions worldwide. With a strong global presence, the company offers its comprehensive range of clinical research and laboratory services to clients across various industries. PPD Inc's key markets include the United States, Europe, Asia Pacific, and Latin America. The company's extensive network and expertise allow it to effectively serve clients on a global scale, helping them navigate the complexities of drug development and deliver innovative solutions. PPD Inc's commitment to expanding its presence in emerging markets reinforces its position as a leading provider of life sciences services worldwide.

PPD Inc represents a strong set of values and a clear corporate philosophy. The company focuses on delivering exceptional customer service, fostering a culture of innovation, and maintaining the highest standards of integrity. PPD Inc aims to provide reliable and efficient solutions in the fields of healthcare and clinical research. With its commitment to excellence, PPD Inc strives to deliver value to its clients and contribute to better patient outcomes. The company's dedication to these principles has established it as a trusted leader in the industry, making PPD Inc a go-to choice for businesses and individuals seeking reliable healthcare and clinical research services.

Po trenutnom kursu akcija PPD kotira 42,07 EUR (47,28 USD).

Akcija PPD (PPD) kotira na 1 berze, uključujući: NASDAQ (PPD).

PPD Inc is an international pharmaceutical company headquartered in the USA with branches in Europe, Asia, Africa, and Australia. The company operates in the areas of clinical research, pharmacovigilance, laboratory services, and consulting, offering comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. One of PPD's main divisions is clinical research. The company works closely with pharmaceutical and biotechnology companies, as well as academic research institutions, to conduct clinical trials. PPD provides all the necessary services for conducting a clinical trial, from study design to subject recruitment, data analysis, and reporting. PPD has extensive experience in all phases of clinical research, from Phase I to Phase IV, and has successfully brought numerous drugs to market in the past. Another important division of PPD is pharmacovigilance. Here, the company collects and analyzes data on adverse drug reactions and provides recommendations for risk minimization. PPD works closely with regulatory authorities worldwide to ensure that all data on adverse drug reactions are accurately recorded and analyzed. In addition, PPD offers laboratory services. The company's portfolio includes a wide range of laboratory tests, including bioanalytical tests and safety tests. PPD has extensive expertise in analyzing biological samples, including blood, urine, saliva, and stool samples. The company specializes in identifying molecular markers that are important for disease diagnosis or monitoring therapy success. PPD also offers comprehensive consulting services. Here, the company supports its clients in the development of new therapies and drugs and provides recommendations for optimizing study design and methods. PPD has extensive experience in working with the FDA and other regulatory authorities worldwide, developing strategies for risk minimization and compliance with regulatory requirements. PPD offers a wide range of products and services specifically tailored to the needs of pharmaceutical and biotechnology companies. The company is committed to offering innovative solutions to its clients to accelerate the development of new drugs and therapies. To this end, PPD has made significant investments in its research and development activities in recent years and works closely with customers and partners to develop new and innovative treatment options. Overall, PPD's business model is oriented towards the needs of the pharmaceutical and biotechnology industry. The company offers comprehensive solutions to its clients for the development, approval, and monitoring of drugs and medical devices. PPD is a key partner for innovation in drug development and has successfully brought numerous therapies and drugs to market in the past.

Prihod se trenutno ne može izračunati za PPD.

Dobit se trenutno ne može izračunati za PPD.

KGV se trenutno ne može izračunati za PPD.

KUV se trenutno ne može izračunati za PPD.

Eulpool score kvaliteta za PPD je 4/10.

ISIN za PPD je US69355F1021. ISIN (International Securities Identification Number) je globalno jedinstveni identifikator za hartije od vrednosti.

WKN za PPD je A2PX5V. WKN (Wertpapierkennnummer) je šestocifreni nemački broj za identifikaciju hartija od vrednosti.

Ticker za PPD je PPD. Simbol tikera se koristi za trgovinu akcijama PPD na berzanskom tržištu.

Фер вредностTerminal
50,12 USD
Над-/ПодцењеностTerminal
Адекватно вредна
Сектор
Индустрија
Алати и услуге науке о животу
Број акција
Запослени
Приход по запосленом
203.542,35 USD
Раст прихода Ø5 година
Раст EBIT Ø5 година
Раст нето добити Ø5 година
Веб сајт ppd.com
Валута
USD
Јавна понуда
6. феб 2020.
ISIN
US69355F1021
CUSIP
69355F102
SEDOL
BL9BT47
Тржишна капитализација
Опсег од 52 недеље
AAQS
4 / 10
PEG
—
P/E однос
P/Ee 2021
29,19
P/Ee 2022
25,56
P/Ee 2023
22,49
P/Ee 2024
19,94
P/Ee 2025
17,50
P/S
P/Se
2,73
EV/EBIT
—
P/B однос
—
ROE (Поврат на капитал)
ROA (Поврат на имовину)
ROCE (Поврат на ангажовани капитал)
ROIC (Поврат на уложени капитал)
4,37 %
Zadnje ažurirano 5. нов 2026. 06:48

Sve ključne metrke i detaljne analize PPD u dubinskoj analizi

Naša analiza akcija za akciju PPD uključuje važne finansijske pokazatelje kao što su prihod, profit, P/E odnos, P/S odnos, EBIT, kao i informacije o dividendama. Takođe, razmatramo aspekte poput akcija, tržišne kapitalizacije, dugova, kapitala i obaveza kompanije PPD. Ako tražite detaljnije informacije o ovim temama, na našim podstranicama vam nudimo opsežne analize: